Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03068793 : Reward Processing in Schizophrenia
AgesMin: 18 Years Max: 30 Years
Inclusion Criteria:

- The subject population will include 18 to 30 year old participants of any gender,
race, and ethnicity. All subjects will be able to speak and understand English.

Schizophrenia subjects:

1. Patients must be diagnosed with DSM-IV schizophrenia, schizophreniform, or
schizoaffective disorder based on a SCID-P interview.

Comparison subjects:

1. Control participants must not have past or present Axis I diagnosis as determined by
the SCID-NP.

Exclusion Criteria:

- All subjects:

1. A hearing deficit greater than 40dB in both ears detected during the hearing

2. Substance dependence, as per clinical judgment, in the past 1 year (except
caffeine and nicotine)

3. A history of significant medical/neurological disease such as cardiac, thyroid,
renal, hepatic or neurological

4. History of head injury with loss of consciousness greater than 15 minutes

5. Any other condition or medication, which in the opinion of the investigator
would preclude participation in the study.

6. Non-English speaking.

Comparison subjects:

1. Any first-degree relative with schizophrenia or bipolar disorder.
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557